1. Home
  2. STIM vs ALIS Comparison

STIM vs ALIS Comparison

Compare STIM & ALIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neuronetics Inc.

STIM

Neuronetics Inc.

N/A

Current Price

$1.32

Market Cap

105.5M

Sector

Health Care

ML Signal

N/A

ALIS

Calisa Acquisition Corp Ordinary shares

N/A

Current Price

$10.03

Market Cap

83.9M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
STIM
ALIS
Founded
2003
2024
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
105.5M
83.9M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
STIM
ALIS
Price
$1.32
$10.03
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$7.00
N/A
AVG Volume (30 Days)
2.2M
49.3K
Earning Date
05-01-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$52,776,000.00
N/A
Revenue This Year
$101.67
N/A
Revenue Next Year
$10.87
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.17
$9.87
52 Week High
$5.34
$10.07

Technical Indicators

Market Signals
Indicator
STIM
ALIS
Relative Strength Index (RSI) 42.63 61.47
Support Level $1.24 $9.87
Resistance Level $2.13 $10.05
Average True Range (ATR) 0.11 0.01
MACD 0.01 -0.00
Stochastic Oscillator 46.77 71.43

Price Performance

Historical Comparison
STIM
ALIS

About STIM Neuronetics Inc.

Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.

About ALIS Calisa Acquisition Corp Ordinary shares

Calisa Acquisition Corp is a blank check company with the purpose of effecting a merger, asset acquisition, stock exchange, stock purchase, reorganization, or similar business combination.

Share on Social Networks: